BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 195 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | -73.0% | 2 | -71.4% | 0.00% | – |
| Q2 2023 | $37 | +164.3% | 7 | -12.5% | 0.00% | – |
| Q1 2023 | $14 | -77.4% | 8 | -27.3% | 0.00% | – |
| Q4 2022 | $62 | -99.7% | 11 | -57.7% | 0.00% | -100.0% |
| Q3 2022 | $21,000 | +16.7% | 26 | +18.2% | 0.00% | 0.0% |
| Q2 2022 | $18,000 | -35.7% | 22 | -31.2% | 0.00% | 0.0% |
| Q1 2022 | $28,000 | +16.7% | 32 | +14.3% | 0.00% | 0.0% |
| Q4 2021 | $24,000 | +71.4% | 28 | +1300.0% | 0.00% | -85.7% |
| Q3 2021 | $14,000 | -12.5% | 2 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $16,000 | -70.9% | 2 | -60.0% | 0.01% | +500.0% |
| Q1 2021 | $55,000 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |